End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
94.78 CNY | -4.94% | -10.03% | -24.72% |
22/04 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
22/04 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
Sales 2024 * | 3.17B 437M 36.48B | Sales 2025 * | 4.02B 556M 46.36B | Capitalization | 14.88B 2.06B 171B |
---|---|---|---|---|---|
Net income 2024 * | 633M 87.42M 7.29B | Net income 2025 * | 826M 114M 9.52B | EV / Sales 2024 * | 4.91 x |
Net Debt 2024 * | 664M 91.69M 7.65B | Net Debt 2025 * | 312M 43.14M 3.6B | EV / Sales 2025 * | 3.78 x |
P/E ratio 2024 * |
23.6
x | P/E ratio 2025 * |
18.1
x | Employees | - |
Yield 2024 * |
1.29% | Yield 2025 * |
1.53% | Free-Float | 55.99% |
1 day | -4.94% | ||
1 week | -10.03% | ||
1 month | -19.96% | ||
3 months | -12.50% | ||
6 months | -16.05% | ||
Current year | -24.72% |
Managers | Title | Age | Since |
---|---|---|---|
Geng Hua Guo
CEO | Chief Executive Officer | 60 | 13/05/13 |
Yi Fan
DFI | Director of Finance/CFO | 47 | 01/16/01 |
Xue Li Zhang
CTO | Chief Tech/Sci/R&D Officer | 43 | 01/13/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qi Feng Zhang
BRD | Director/Board Member | 51 | 01/19/01 |
Lin Wu
BRD | Director/Board Member | 65 | 28/22/28 |
Geng Hua Guo
CEO | Chief Executive Officer | 60 | 13/05/13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 94.78 | -4.94% | 1,365,341 |
30/24/30 | 99.71 | -1.15% | 792,616 |
29/24/29 | 100.9 | -1.97% | 885,630 |
28/24/28 | 102.9 | -1.29% | 1,413,097 |
27/24/27 | 104.2 | -1.04% | 1,487,139 |
End-of-day quote Shanghai S.E., May 31, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.72% | 2.06B | |
-5.67% | 27.45B | |
+18.78% | 24.56B | |
+5.34% | 11.01B | |
+11.49% | 5.11B | |
+14.97% | 4.33B | |
-13.08% | 3.62B | |
+5.01% | 3.5B | |
-5.98% | 2.8B | |
+25.30% | 2.75B |
- Stock Market
- Equities
- 688639 Stock